ONCOmmunity

MCP1-Induced Epithelial-Mesenchymal Transition in Head and Neck Cancer by AKT Activation.

By: Ching-Chih Lee, Hsu-Chueh Ho, Yu-Chieh Su, Moon-Sing Lee, Shih-Kai Hung, Chun-Hsuan Lin

Department of Otolaryngology, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan, R.O.C. School of Medicine, Tzu Chi University, Hualian, Taiwan, R.O.C.
2015-5-31; doi:

Abstract

Aim

To explore whether monocyte chemotactic protein-1 (MCP1) is associated with the epithelial-mesenchymal transition (EMT) and neck metastases in head and neck cancer (HNC).

Materials

MCP1 and its related protein were evaluated using western blotting, and a migration assay for HNC cell lines. Thirty-five patients with HNC were recruited for the evaluation of MCP1 expression and pathologically-proven neck metastases from their tissue specimens.

Results

MCP1 changed the phenotype of OML-1 cells to a spindle shape, with increased mobility. In OML3 cells, MCP1 knockdown with siRNA blocked EMT. Activation of protein kinase B (AKT) was positively associated with the EMT phenotype, and this transition was abrogated with a phosphoinositide 3 kinase (PI3K) inhibitor. By comparing clinical outcomes, the histological MCP1 score was associated with pathological neck metastases (p=0.027).

Conclusion

The overexpression of MCP1 in HNC cells may partially induce EMT through the AKT pathway. A high cellular expression of MCP1 was associated with pathological neck metastases.